Overview
Colorectal cancer (CRC) is one of the most common cancers worldwide and a leading cause of cancer-related death globally. In China, incidence rates have risen sharply over the past two decades, driven by changing dietary patterns and lifestyle factors. Fortunately, colorectal cancer is also one of the most treatable cancers when detected early — and Shanghai's leading specialists have built comprehensive, full-spectrum care systems that significantly improve patient outcomes at every stage.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top colorectal cancer specialists, providing end-to-end support from remote consultation through to post-treatment follow-up.
Understanding Colorectal Cancer
What Is Colorectal Cancer?
Colorectal cancer develops in the colon or rectum — the final sections of the digestive tract. Most colorectal cancers begin as small, benign growths called polyps, which can be detected and removed during colonoscopy before they become cancerous. This makes regular screening one of the most powerful tools in colorectal cancer prevention.
Common Symptoms
- Change in bowel habits (diarrhea, constipation, or narrowing of stool)
- Blood in stool or rectal bleeding
- Persistent abdominal discomfort, cramping, or pain
- Feeling that the bowel does not empty completely
- Unexplained weight loss and fatigue
- Anaemia (low red blood cell count)
Risk Factors
- Age over 50 (risk increases significantly with age)
- Personal or family history of colorectal cancer or polyps
- Inflammatory bowel disease (Crohn's disease or ulcerative colitis)
- High-fat, low-fiber diet; red and processed meat consumption
- Sedentary lifestyle, obesity, smoking, and heavy alcohol use
- Hereditary syndromes (Lynch syndrome, FAP)
Diagnosis & Staging
Accurate diagnosis and staging are the foundation of effective colorectal cancer treatment. At Shanghai's leading centers, the standard workup includes:
- Colonoscopy with biopsy — definitive diagnosis and polyp removal
- CT scan (chest/abdomen/pelvis) — staging and metastasis assessment
- MRI of the pelvis — essential for rectal cancer staging and surgical planning
- Endoscopic ultrasound (EUS) — for early rectal cancer staging
- PET-CT — selected cases for occult metastasis
- Molecular profiling — RAS/RAF mutation, MSI/MMR status, HER2 for targeted and immunotherapy eligibility
- CEA and CA19-9 — tumor markers for monitoring
Treatment Options in Shanghai
Early Detection & Endoscopic Treatment
For early-stage colorectal cancer and precancerous polyps, endoscopic resection (EMR or ESD) offers a curative, minimally invasive option that avoids the need for surgery entirely. Shanghai's leading endoscopists are among the most experienced in Asia for complex colorectal endoscopic procedures.
Minimally Invasive Surgery
For resectable colorectal cancer, laparoscopic and robotic colectomy or rectal resection is the standard of care at Shanghai's top centers. Minimally invasive approaches offer patients smaller incisions, reduced blood loss, faster recovery, and equivalent oncological outcomes to open surgery. For rectal cancer, sphincter-preserving surgery — avoiding a permanent colostomy — is a priority wherever oncologically feasible.
Full-Spectrum Care: Early to Advanced Disease
Shanghai's leading colorectal cancer teams have developed comprehensive, full-spectrum care systems covering every stage of disease:
- Early-stage (Stage I–II): Endoscopic or surgical resection, with adjuvant chemotherapy for high-risk Stage II
- Locally advanced (Stage III): Surgery + adjuvant chemotherapy (FOLFOX, CAPOX); neoadjuvant chemoradiotherapy for rectal cancer
- Metastatic (Stage IV): Systemic therapy (chemotherapy + targeted therapy/immunotherapy) ± liver/lung metastasectomy for resectable metastases
Targeted Therapy & Immunotherapy
- RAS wild-type: Anti-EGFR therapy (cetuximab, panitumumab) + chemotherapy
- BRAF V600E-mutant: BRAF + MEK inhibitor combination (encorafenib + binimetinib)
- HER2-amplified: Trastuzumab + pertuzumab or trastuzumab deruxtecan
- MSI-H / dMMR: Pembrolizumab (first-line standard); excellent immunotherapy response
- VEGF inhibition: Bevacizumab or ramucirumab + chemotherapy
Why Choose Shanghai for Colorectal Cancer Treatment?
- Highest surgical volume in Asia — Shanghai surgeons perform thousands of colorectal resections annually, with outcomes data rivaling leading Western centers
- Full-spectrum care systems — from early detection and endoscopic treatment through to complex metastatic disease management
- Sphincter-preserving expertise — advanced techniques to avoid permanent colostomy wherever possible
- Comprehensive molecular profiling — full biomarker workup to guide personalized systemic therapy
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Prof. Xu Jianmin — Zhongshan Hospital, Fudan University
Prof. Xu Jianmin (许剑民) is one of China's foremost colorectal cancer surgeons, based at Zhongshan Hospital, Fudan University — consistently ranked among China's top hospitals and a national center of excellence for colorectal cancer care.
National Recognition: Shanghai Craftsman Innovation Studio
Prof. Xu leads the "Colorectal Minimally Invasive Diagnosis and Treatment Craftsman Innovation Studio" — awarded the prestigious 2024 Shanghai Municipal Craftsman Innovation Studio designation. This recognition reflects not only Prof. Xu's individual surgical excellence but the systematic, team-based approach to colorectal cancer care that his group has pioneered.
Full-Spectrum Care System
Prof. Xu's team has built a comprehensive, full-spectrum colorectal cancer care system covering early, intermediate, and advanced disease — integrating early detection, minimally invasive surgery, systemic therapy, and long-term follow-up into a coordinated treatment pathway. This systematic approach has significantly improved 5-year survival rates for colorectal cancer patients treated at Zhongshan Hospital.
Clinical Expertise
- Minimally invasive colorectal surgery — laparoscopic and robotic colectomy and rectal resection
- Early detection and early treatment — endoscopic diagnosis and resection of early colorectal cancer and polyps
- Full-spectrum colorectal cancer management — coordinated care from diagnosis through to survivorship
- Complex colorectal cancer surgery — locally advanced and recurrent disease
For international patients, Prof. Xu's team offers remote pre-consultation review of colonoscopy reports, imaging, and pathology, enabling a personalized treatment plan to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Prof. Xu Jianmin and other top colorectal cancer specialists at Zhongshan Hospital
- ✅ Medical record, colonoscopy report, and imaging translation and pre-consultation review
- ✅ Second opinion facilitation
- ✅ Hospital admission and surgical scheduling support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with colorectal cancer and would like to explore treatment options in Shanghai, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0 commentaire